Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 306,585 | 231,413 |
| Cost of Goods | 186,654 | 146,729 |
| Gross Profit | 119,931 | 84,684 |
| Operating Expenses | 55,524 | 42,450 |
| Operating Income | 65,061 | 42,963 |
| Interest Expense | 40,691 | 12,789 |
| Other Income | 2,740 | 2,533 |
| Pre-tax Income | 27,110 | 32,707 |
| Income Tax | 7,837 | 15,561 |
| Net Income Continuous | 17,877 | 17,124 |
| Net Income Extraordinary | -29,101 | N/A |
| Net Income | $-11,224 | $17,124 |
| EPS Basic Total Ops | -0.40 | 0.86 |
| EPS Basic Continuous Ops | 0.64 | 0.86 |
| EPS Diluted Total Ops | -0.35 | 0.86 |
| EPS Diluted Continuous Ops | 0.56 | 0.86 |
| EBITDA(a) | $90,431 | $58,606 |